Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThorpe Regulatory News (TFW)

Share Price Information for Thorpe (TFW)

Share Price is delayed by 15 minutes
Get Live Data
258.00    7.00 (2.79%)
Bid:
246.00
Ask:
258.00
Spread: 12.00 (4.878%)
Market Cap: £289.57m
TFW Live PriceLast checked at - London Stock Exchange

Intraday Thorpe Share Chart

Directorate Change

3 Jul 2017 14:14

RNS Number : 9548J
Thorpe(F.W.) PLC
03 July 2017
 

3rd July 2017

F W Thorpe Plc (the "Company")

Directorate Changes

 

F W Thorpe Plc announces the following changes to the board structure:

 

Mr Andrew Thorpe will step down as Executive Chairman and Joint Chief Executive and take up a role as an Executive Director on a part-time basis.

 

The position of Chairman and Joint Chief Executive will be assumed by Mr Mike Allcock, currently Joint Chief Executive and Managing Director of Thorlux Lighting, the largest company within the Group. Mike has been responsible for driving the growth at Thorlux for a number of years and will continue this role as well as influencing product development and the adoption of new product technology across the Group.

 

Mr Craig Muncaster will become Joint Chief Executive whilst retaining the position of Group Financial Director. Craig has been with the Group for over seven years and has recently led the successful delivery of the acquisition strategy including the notable success of integrating both the Portland and Lightronics businesses in recent years.

 

Mr James Thorpe will become an Executive Director of the Group and Business Development Director of Thorlux Lighting. James has been with the Group since 2013 in the role of Business Development Manager for Thorlux and has been responsible for securing a number of high profile projects which have contributed to the growth of revenue derived from the healthcare sector.

 

Andrew Thorpe, Chairman of F W Thorpe Plc said:

 

"There comes a time! The salmon, bass and the 18th beckon and deserve a little more of my attention. I have enjoyed every moment of my time at F W Thorpe Plc and hope to contribute more yet even from my lower standing! 

 

With the current executive team being responsible for delivering the positive results we have seen over a number of years, this is very much "business as usual". The structure outlined above has served the Company well and resulted in the successful group we see today."

 

The new board structure will be available on our website later today.

 

 

Additional information in respect of James Thorpe:

James Edward Thorpe, aged 40, holds 1,371,450 ordinary shares in the Company. There is no further information to be disclosed under schedule 2(g) and Rule 17 of the AIM Rules in respect of James Thorpe's appointment as a Director of the Company. 

 

 

For further information, please contact:

 

 

F W Thorpe Plc

Andrew Thorpe - Chairman and Joint Chief Executive Tel: 01527 583200

Craig Muncaster - Group Financial Director

 

 

N+1 Singer - Nominated Adviser

Richard Lindley Tel: 020 7496 3000

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOALLFLVDVIVIID
Date   Source Headline
7th May 202610:24 amRNSTransaction in Own Shares
6th May 20269:45 amRNSTransaction in Own Shares
7th Apr 202610:22 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 202610:09 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSInterim Results
7th Jan 20262:51 pmRNSHolding(s) in Company
24th Dec 20259:09 amRNSTransaction in Own Shares
24th Dec 20259:09 amRNSTransaction in Own Shares
23rd Dec 20258:51 amRNSTransaction in Own Shares
23rd Dec 20258:51 amRNSTransaction in Own Shares
26th Nov 20259:04 amRNSPDMR Dealing
21st Nov 202511:13 amRNSResult of AGM
20th Nov 20253:15 pmRNSAGM Statement
20th Oct 20256:14 pmRNSHolding(s) in Company
20th Oct 202510:26 amRNSTransaction in Own Shares
9th Oct 202510:19 amRNSTransaction in Own Shares
8th Oct 202510:07 amRNSTransaction in Own Shares
3rd Oct 20257:00 amRNSFinal Results
18th Jun 20254:40 pmRNSTransaction in Own Shares
30th May 202511:12 amRNSTransaction in Own Shares
23rd Apr 20259:45 amRNSTransaction in Own Shares
7th Apr 20258:20 amRNSTransaction in Own Shares
2nd Apr 20259:01 amRNSTransaction in Own Shares
1st Apr 20258:42 amRNSTransaction in Own Shares
27th Mar 20258:07 amRNSTransaction in Own Shares
21st Mar 20258:55 amRNSTransaction in Own Shares
20th Mar 20257:00 amRNSTransaction in Own Shares
6th Mar 20257:00 amRNSInterim Results
3rd Dec 202410:00 amRNSGrant of Options
22nd Nov 20243:36 pmRNSResult of AGM
21st Nov 20243:15 pmRNSAGM Statement
30th Oct 20243:25 pmRNSPDMR Dealing
3rd Oct 20247:00 amRNSFinal Results
15th Jul 20244:30 pmRNSExercise of Options, Treasury Shares and TVR
1st Jul 20244:46 pmRNSExercise of Options, Treasury Shares and TVR
31st May 202410:30 amRNSGrant of Options
31st May 202410:00 amRNSExercise of Options, Treasury Shares and TVR
23rd May 202410:00 amRNSDirectorate Changes
23rd Apr 20244:25 pmRNSPDMR & PCA Dealing
23rd Apr 202412:30 pmRNSResult of General Meeting
22nd Mar 202412:30 pmRNSNotice of GM
14th Mar 20247:00 amRNSInterim Results
16th Jan 202410:00 amRNSDirectorate Change
11th Dec 202310:00 amRNSExercise of Options, Treasury Shares and TVR
16th Nov 20235:21 pmRNSResult of AGM
16th Nov 20233:15 pmRNSAGM Statement
12th Oct 20237:00 amRNSFinal Results
4th Jul 20231:15 pmRNSDirectorate Changes
20th Apr 20234:02 pmRNSPDMR Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.